glp-1 for perimenopause weight gain GLP-1s, Obesity, and Menopause: Benefits and Risks My Journey Microdosing a GLP-1

doi: 10.1016/S0140-6736(19)31149-3 83 HusainMBirkenfeldALDonsmarkMDunganKEliaschewitzFGFrancoDRet al

Animal model studies suggest that liraglutide significantly inhibits liver cancer occurrence in diabetic mouse models, and this inhibitory effect may be partly attributed to its ability to improve the high-glucose microenvironment [44]

GLP-1s can literally be lifesaving but In the long-term.GLP-1s with successful behavior change fortified by a well-trained and effective coach is the likely the best plan to treat obesity

Slower motility is a risk factor, not a guarantee

Mechanism of action of DPP4 inhibitors The action mechanism of Dipeptidyl peptidase-4 (DPP4) inhibitors revolves around inhibiting the activity of DPP4, the enzyme responsible for degrading incretin hormones such as glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP)

I get that